Multimodal Imaging of Constrictive Pericarditis Induced by Long-term Pergolide Treatment for Parkinson's Disease

被引：0

作者：

Aoyagi, Hiroyuki ^{[1
]}

Tsujinaga, Shingo ^{[1
]}

Takahashi, Yuki ^{[1
]}

Naito, Seiichiro ^{[1
]}

Sato, Takuma ^{[1
]}

Otsuka, Takuya ^{[1
]}

Tamaki, Yoji ^{[1
]}

Motoi, Ko ^{[1
]}

Ishizaka, Suguru ^{[1
]}

Chiba, Yasuyuki ^{[1
]}

Kamiya, Kiwamu ^{[1
]}

Iwano, Hiroyuki ^{[1
]}

Nagai, Toshiyuki ^{[1
]}

Wakasa, Satoru ^{[1
]}

Anzai, Toshihisa ^{[1
]}

机构：

[1] Hokkaido Univ, Fac Med, Dept Cardiovasc Med, Sapporo, Japan

来源：

INTERNAL MEDICINE | 2023年 / 62卷 / 24期

关键词：

constrictive pericarditis; multimodal imaging; Parkinson's disease; pergolide;

D O I：

10.2169/internalmedicine.1381-22

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We herein report the first case of constrictive pericarditis (CP) induced by long-term pergolide treatment for Parkinson's disease that was assessed using multimodal imaging in a 72-year-old patient with leg edema and dyspnea. The patient was correctly diagnosed with CP using multimodal imaging and successfully treated with pericardiectomy. The treatment history of Parkinson's disease and pathological findings of the removed pericardium suggested that long-term pergolide was the cause of CP. Properly recognizing pergolide as the cause of CP and accurately diagnosing CP using multimodal imaging may contribute to the early detection and treatment of pergolide-induced CP.

引用

页码：3637 / 3641

页数：5

共 50 条

[21] Multimodality imaging and long-term outcome after pericardiectomy for constrictive pericarditis: a single center case series
Paelinck, B. P.
Laga, S.
De Bock, D.
Bosmans, J. M.
Claeys, M. J.
Haine, S.
Vermeulen, T.
Parizel, P. M.
Rodrigus, I. E.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2019, 20 : 371 - 371
[22] Long-term efficacy of posteroventral pallidotomy in the treatment of Parkinson's disease
Lai, EC
Jankovic, J
Krauss, JK
Ondo, WG
Grossman, RG
NEUROLOGY, 2000, 55 (08) : 1218 - 1222
[23] Long-term retention rate of pramipexole in the treatment of Parkinson's disease
Keranen, Tapani
Tuhkasaari, Mervi
Kuusisto, Hanna
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (09) : 955 - 956
[24] Long-term treatment with dopamine agonists in idiopathic in Parkinson's disease
H. Reichmann
Journal of Neurology, 2000, 247 (Suppl 4) : IV17 - IV19
[25] Long-term safety and efficacy of selegiline in the treatment of Parkinson's disease
Maki-Ikola, O
Heinonen, E
Lammintausta, R
NEUROCHEMISTRY: CELLULAR, MOLECULAR, AND CLINICAL ASPECTS, 1997, : 331 - 337
[26] Long-term treatment with dopamine agonists in idiopathic Parkinson's disease
Reichmann, H
JOURNAL OF NEUROLOGY, 2000, 247 : 17 - 19
[27] Long-term retention rate of pramipexole in the treatment of Parkinson’s disease
Tapani Keränen
Mervi Tuhkasaari
Hanna Kuusisto
European Journal of Clinical Pharmacology, 2009, 65 : 955 - 956
[28] Long-term retention rate of entacapone in the treatment of Parkinson's disease
Keraenen, T.
Tuhkasaari, M.
Kuusisto, H.
EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (04) : E30 - E30
[29] Long-term course of Parkinson's disease
Ebersbach, G.
NERVENHEILKUNDE, 2010, 29 (06) : 345 - 350
[30] Pergolide: a useful agonist for the treatment of Parkinson's disease
Bonnet, AM
Houeto, JL
REVUE NEUROLOGIQUE, 2002, 158 (6-7) : 744 - 745

← 1 2 3 4 5 →